Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2011.12.21
华英证券有限责任公司关于《深圳市Z6尊龙药业股份有限公司股票期权激励妄想(草案)》之独...
2011.12.21
第二届监事会第九次聚会决议通告
2011.12.21
股票期权激励妄想激励工签字单
2011.12.20
停牌通告
2011.12.17
关于替换保荐代表人的通告
2011.12.01
关于投资设立合资企业希望的通告
2011.12.01
关于公司高级治理职员告退的通告
2011.11.03
关于控股子公司完成增资工商变换挂号的通告
2011.11.03
关于向控股子公司提供委托贷款的希望通告
2011.10.19
中国建银投资证券有限责任公司关于公司有关委托贷款事项的核查意见
第一页
上一页
134
135
136
137
138
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】